Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
This study has been terminated.
(stopped due to slow recruitment and no effect)
Sponsor:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT00427583
First received: January 25, 2007
Last updated: August 6, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |